4.5 Article

miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression

Journal

PROSTATE CANCER AND PROSTATIC DISEASES
Volume 13, Issue 4, Pages 356-361

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/pcan.2010.32

Keywords

androgen; LNCaP cells; microRNA; miR-148a; CAND1

Funding

  1. MEXT
  2. NIBIO
  3. Japan Society for the Promotion of Science
  4. Ministry of Health, Labor and Welfare
  5. Promotion and Mutual Aid Corporation for Private School of Japan
  6. Grants-in-Aid for Scientific Research [21591170] Funding Source: KAKEN

Ask authors/readers for more resources

Recent advances in cancer biology reveal that microRNAs (miRNAs) are involved in the regulation of cancer-related genes, or they function as tumor suppressors or oncogenes. In prostate cancer, evidence has accumulated for the contribution of the androgen-dependent gene network to tumor growth, although the precise functions of miRNAs in prostate cancer remain to be investigated. Here, we identified androgen-responsive miRNAs by the short RNA sequencing analysis in LNCaP prostate cancer cells. Among 10 miRNAs with known sequences, we have determined that miR-148a reduces the expression of cullin-associated and neddylation-dissociated 1 (CAND1), a negative regulator of SKP1-Cullin1-F-box (SCF) ubiquitin ligases, by binding to the 3'-untranslated region of CAND1 mRNA. CAND1 knockdown by small interfering RNA promoted the proliferation of LNCaP cells. Our study indicates the potential contribution of miR-148a to the growth of human prostate cancer. Prostate Cancer and Prostatic Diseases (2010) 13, 356-361; doi: 10.1038/pcan.2010.32; published online 7 September 2010

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available